Peter Falkai

19PUBLICATIONS

190CO-AUTHORS

Cellular nervous systemExercise physiologySensory systemsNeurology and neuromuscular diseasesPharmacogenomics

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (19)

Sort by Publication Date:

|Jun 16, 2026

Antagonizing NRG1-ERBB4 signaling pathway with spironolactone for the treatment of schizophrenia: results of a randomized controlled drug repositioning clinical trial.

|May 25, 2026

Aerobic Exercise for Cognitive and Functional Enhancement in Schizophrenia: Evidence, Mechanisms, and Practical Recommendations.

|Jan 23, 2026

The link between GABA levels and P300 abnormalities in schizophrenia spectrum disorders: regional and symptom-based insights.

Berkhan Karslı, Verena Meisinger, Genc Hasanaj

|Nov 10, 2025

Reducing functional dysconnectivity in people with schizophrenia spectrum disorders.

Stephan Wunderlich, Daniel Keeser, Johanna Spaeth

|Oct 04, 2025

Periodic and Aperiodic Alterations of Resting-State EEG in Schizophrenia Spectrum Disorders: Cognitive and Clinical Insights.

Genc Hasanaj, Iris Jaeger, Berkhan Karsli

|Sep 09, 2025

Clinical deep phenotyping of treatment response in schizophrenia (CDP-STAR): design and methodology of a prospective multimodal observational study.

Vladislav Yakimov, Lara Neuwinger, Madeleine M Weber

Pageof 4

Frequent Collaborators

Daniel Keeser

Andrea Schmitt

Isabel Maurus

Sergi Papiol

Emanuel Boudriot

Florian J Raabe

Peter Falkai

Urs Heilbronner

Vladislav Yakimov

Bob O Vogel

Frequent Collaborators

Daniel Keeser

Andrea Schmitt

Isabel Maurus

Sergi Papiol